Leo Puri, an independent director on the board of Tata Sons, has stepped down following the conclusion of his term, as reported by The Economic Times. Puri chose not to seek a renewal of his position.

With over 30 years of experience in finance and consultancy, Puri is a well-respected figure in the financial sector. His career includes significant roles at McKinsey, Warburg Pincus, and UTI Asset Management Company. His departure from the Tata Sons board comes shortly after he resigned from the board of Hindustan Unilever (HUL), one of India's leading consumer goods firms.

Leo Puri's resignation from HUL was attributed to an increase in his board responsibilities, including a forthcoming appointment to a global entity's board. His exit from HUL will officially take effect on June 30, 2025. Following this resignation, he will also step down from his roles as Chairperson of the Risk Management Committee, ESG Committee, and Independent Committee, as well as a member of the Audit Committee, as noted in a regulatory filing on March 13.

Leo Puri was initially appointed as an independent director for HUL on October 12, 2018, and was reappointed on the same date in 2023. In addition to his roles at Tata Sons and HUL, he serves as an independent director on the boards of Dr. Reddy's Laboratories and Fortis Healthcare, where he is also the chairperson.

In March 2024, Puri joined Apax Partners LLP as an advisor and chairman for Apax India. The firm highlighted his extensive experience in private equity and financial services, having held senior positions at UTI Asset Management, McKinsey & Company, and Warburg Pincus in India. Additionally, in 2020, he became the chairman of JPMorgan Chase for South and Southeast Asia.